01.01.04
Ester-C® manufacturer Zila Nutraceuticals, Phoenix, AZ, will launch its new Ester-E™ product early this year. The Ester-E technology is based upon a patented process for manufacturing tocopherol phosphate, as well as numerous patent-pending applications, to create an enhanced form of vitamin E.
In other news, the company has entered into a long-term licensing agreement with Australia-based Vital Health Sciences, granting Zila the exclusive rights in the dietary supplement market for certain issued and pending patents, know-how and data pertaining to tocopherol phosphate in the U.S., Canada and Indonesia. Zila also has a right of first refusal for other international markets under the agreement.
In other news, the company has entered into a long-term licensing agreement with Australia-based Vital Health Sciences, granting Zila the exclusive rights in the dietary supplement market for certain issued and pending patents, know-how and data pertaining to tocopherol phosphate in the U.S., Canada and Indonesia. Zila also has a right of first refusal for other international markets under the agreement.